AbbVie Q4 Earnings: Strong Revenue Results, Ambitious Forecasts - A Buy With Caveats

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.AbbVie Inc. (NYSE: ABBV ) stock has surged by over 7% in trading so far today, as the company released its Q4 earnings and full-year 2024 earnings, and provided guidance fo ...